Skip to main content
Retour
Watch Compare

HEALTHY EXTRACTS INC.

Qualité des données : 100%
HYEX
OTC Manufacturing Chemicals
2,00 €
0,00 € (0,00%)
Cap. Boursière: 33,74 M
Prix
2,00 €
Cap. Boursière
33,74 M
Fourchette du Jour
2,00 € — 2,00 €
Fourchette 52 Semaines
0,81 € — 4,25 €
Volume
100
Ouverture 2,00 €
Moyenne 50J / 200J
2,12 €
5,51% below
Moyenne 50J / 200J
2,07 €
3,18% below

Quick Summary

Points Clés

Revenue grew 28,08% annually over 5 years — strong growth
ROE of 163,99% indicates high profitability
Net margin of 445,95% shows strong profitability
Generating 165 520,0 in free cash flow
P/E of 1,68 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 16,85%

Croissance

Revenue Growth (5Y)
28,08%
Au-dessus de la moyenne du secteur (1,82%)
Revenue (1Y)44,93%
Earnings (1Y)4,58%
FCF Growth (3Y)N/A

Qualité

Return on Equity
163,99%
Au-dessus de la moyenne du secteur (-53,41%)
ROICN/A
Net Margin445,95%
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio1,47
Interest CoverageN/A

Valorisation

PE (TTM)
1,68
Au-dessus de la moyenne du secteur (-1,48)
P/B Ratio1,40
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E 1,7 -1,5
P/B 1,4 1,6
ROE % 164,0 -53,4
Net Margin % 446,0 -41,5
Rev Growth 5Y % 28,1 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 44,93% Revenue Growth (3Y) 34,72%
Earnings Growth (1Y) 4,58% Earnings Growth (3Y) 4,75%
Revenue Growth (5Y) 28,08% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 4,51 M Net Income (TTM) 20,12 M
ROE 163,99% ROA 140,28%
Gross Margin 53,69% Operating Margin N/A
Net Margin 445,95% Free Cash Flow (TTM) 165 520,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1,47
Interest Coverage N/A Asset Turnover 0,31
Working Capital 554 705 Tangible Book Value 23,85 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 1,68 Forward P/E N/A
P/B Ratio 1,40 P/S Ratio 7,48
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 0,49%
Market Cap 33,74 M Enterprise Value 33,74 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0,27
FCF / Share 0,01 OCF / Share 0,01
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 0,82%
SBC-Adj. FCF N/A Growth Momentum 16,85

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 4,51 M 3,11 M 2,49 M 2,25 M 1,68 M
Net Income 20,12 M 19,24 M 18,34 M -983 121,0 -1,99 M
EPS (Diluted) — — — — —
Gross Profit 2,42 M 1,91 M 1,62 M 1,37 M 695 078,0
Operating Income — — — — —
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — 5 100,0
Interest Expense -210 279,0 -186 252,0 -176 948,0 -64 690,0 -52 453,0
Income Tax 0,0 0,0 0,0 — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 27,82 M 2,38 M 2,64 M 2,78 M 3,03 M
Total Liabilities 3,80 M — — — —
Shareholders' Equity 24,03 M 410 377,0 954 590,0 1,88 M 2,47 M
Total Debt — — — — —
Cash & Equivalents — — — — —
Current Assets 1,33 M 1,66 M 1,90 M 1,99 M 2,31 M
Current Liabilities 1,69 M 1,97 M 1,68 M 902 788,0 558 841,0